American International Group Inc. Sells 5,298 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

American International Group Inc. lowered its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) by 4.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 124,541 shares of the company’s stock after selling 5,298 shares during the period. American International Group Inc. owned approximately 0.14% of Acadia Healthcare worth $9,684,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Oppenheimer & Co. Inc. purchased a new stake in shares of Acadia Healthcare in the 3rd quarter worth approximately $390,000. Swiss National Bank increased its holdings in shares of Acadia Healthcare by 0.9% during the third quarter. Swiss National Bank now owns 202,368 shares of the company’s stock valued at $14,228,000 after acquiring an additional 1,900 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Acadia Healthcare by 4.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 996,704 shares of the company’s stock worth $70,078,000 after purchasing an additional 38,664 shares during the last quarter. Vanguard Personalized Indexing Management LLC boosted its stake in Acadia Healthcare by 19.1% in the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 6,989 shares of the company’s stock worth $491,000 after purchasing an additional 1,119 shares in the last quarter. Finally, Pathstone Family Office LLC grew its position in Acadia Healthcare by 29.3% during the 3rd quarter. Pathstone Family Office LLC now owns 7,241 shares of the company’s stock valued at $509,000 after purchasing an additional 1,642 shares during the last quarter.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC opened at $69.42 on Friday. The stock has a market cap of $6.44 billion, a PE ratio of -495.82, a price-to-earnings-growth ratio of 2.15 and a beta of 1.32. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The firm has a fifty day moving average price of $70.32 and a 200-day moving average price of $76.44. Acadia Healthcare Company, Inc. has a 1 year low of $62.04 and a 1 year high of $87.77.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The business had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. During the same period last year, the firm earned $0.75 earnings per share. The business’s quarterly revenue was up 9.1% on a year-over-year basis. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.52 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Barclays decreased their target price on shares of Acadia Healthcare from $91.00 to $89.00 and set an “overweight” rating for the company in a report on Wednesday, May 15th. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, May 21st. Bank of America reduced their target price on Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a report on Wednesday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price for the company in a research report on Thursday, April 25th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $87.56.

Read Our Latest Research Report on ACHC

Acadia Healthcare Company Profile

(Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Featured Articles

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.